← All stocks

Elanco Animal Health Inc

ELAN Net buying
CIK 0001739104 #870 in the set updated 17 Sep 2026
Bought (12 mo)
$2.61M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$2.61M
+$2.61M against sales at will

By person

26 insiders · 11 transactions
43.3×

Jeffrey Simmons holds 43.3 times base salary in stock. $52.03M of shares against $1.20M in salary for 2025.

Salary from the company's own proxy. The shares are what Jeffrey Simmons last reported holding, valued at $23.40, the price Common Stock was last bought or sold at on the open market here, on 20 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kurzius Lawrence Erik
Director
$1.15M (2)
+$1.15M
188,647
0.0378%
$4.41M
+157.4%
Simmons Jeffrey N
PRESIDENT, CEO AND DIRECTOR
$578.34K (2)
+$578.34K
2,223,869
0.4451%
$52.03M
+47.7%
VanHimbergen Robert M
EVP and CFO
$247.35K (2)
+$247.35K
137,516
0.0275%
$3.22M
+1,583%
Herendeen Paul
Director
$236.85K (1)
+$236.85K
111,687
0.0224%
$2.61M
+98.3%
Modi Rajeev A.
SEE REMARKS
$195.92K (2)
+$195.92K
160,812
0.0322%
$3.76M
+118.2%
Harrington Michael J
Director
$109.10K (1)
+$109.10K
131,451
0.0263%
$3.08M
+62.1%
O'Neill Shiv
GC AND CORP SEC
$94.27K (1)
+$94.27K
87,832
0.0176%
$2.06M
+269.5%
Cabral Ramiro Martin
SEE REMARKS
283,874
0.0568%
$6.64M
+67.9%
de Brabander Ellen
SEE REMARKS
280,821
0.0562%
$6.57M
+144.4%
HOOVER R DAVID
Director
261,451
0.0523%
$6.12M
−0.7%
Kinard David S
SEE REMARKS
214,264
0.0429%
$5.01M
+39.8%
Bettington Timothy J
SEE REMARKS
143,261
0.0287%
$3.35M
+34.7%
YOUNG TODD S.
SEE REMARKS
142,366
0.0285%
$3.33M
+278.9%
Anand Kapila K
Director
111,847
0.0224%
$2.62M
+68.2%
GARCIA ART A
Director
108,152
0.0216%
$2.53M
+72.2%
Scots-Knight Denise
Director
105,588
0.0211%
$2.47M
+75.3%
McDonald Kirk P
Director
105,588
0.0211%
$2.47M
+75.3%
McArdle Grace
EVP, MANUFACTURING AND QUALITY
103,705
0.0208%
$2.43M
+105.1%
Correia de Simas Jose Manuel
SEE REMARKS
101,017
0.0202%
$2.36M
+103.0%
DOYLE WILLIAM F
Director
94,499
0.0189%
$2.21M
+23.8%
Kochevar Deborah Turner
Director
94,392
0.0189%
$2.21M
+54.2%
BILBREY JOHN P
Director
78,400
0.0157%
$1.83M
+30.2%
Meer James M
CHIEF ACCOUNTING OFFICER
66,732
0.0134%
$1.56M
+49.1%
Ma Stacey
Director
29,727
0.0059%
$695.55K
Turner Kathy V
Director
13,838
0.0028%
$323.78K
Wallace Craig S.
Director
13,838
0.0028%
$323.78K
Insider
Date
Role
Action
Shares
Price
Amount
Kurzius Lawrence Erik
20 Aug 2026
Director
Buy
40,000
$23.40
$935.92K
O'Neill Shiv
18 Aug 2026
GC AND CORP SEC
Buy
3,998
$23.58
$94.27K
Harrington Michael J
12 Aug 2026
Director
Buy
5,000
$21.82
$109.10K
Herendeen Paul
7 Aug 2026
Director
Buy
10,000
$23.69
$236.85K
VanHimbergen Robert M
7 Aug 2026
EVP and CFO
Buy
4,200
$23.08
$96.93K
Simmons Jeffrey N
15 May 2026
PRESIDENT, CEO AND DIRECTOR
Buy indirect
4,971
$20.09
$99.84K
Modi Rajeev A.
15 May 2026
SEE REMARKS
Buy
4,911
$20.35
$99.94K
Kurzius Lawrence Erik
12 Dec 2025
Director
Buy
10,000
$21.30
$213.00K
Simmons Jeffrey N
11 Dec 2025
PRESIDENT, CEO AND DIRECTOR
Buy indirect
22,000
$21.75
$478.50K
VanHimbergen Robert M
11 Dec 2025
EVP and CFO
Buy
6,950
$21.64
$150.43K
Modi Rajeev A.
11 Dec 2025
SEE REMARKS
Buy
4,500
$21.33
$95.99K

What was left out

Form 4 filings counted 129
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,980,171
History held since 26 Sep 2018